Trials / Completed
CompletedNCT01323868
Endogenous Endophthalmitis in the Inpatient Setting
Endogenous Endophthalmitis Rates, Clinical Course, and Outcomes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 145 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the rate of endogenous endophthalmitis in patients admitted to Stanford Hospital with a systemic infection and positive blood cultures, as this may improve the clinical care of this population of patients.
Detailed description
Some patients admitted to the hospital have blood-borne infections. Occasionally, these blood infections can end up inside the eye and cause an infection inside the eye (called endogenous endophthalmitis). Prior to modern and rapid treatment of systemic infections, the rate of endogenous endophthalmitis was reported to be 37% in 1982. By 1997, the rate was reported to be 2.8%. This study aims to determine the rate of endogenous endophthalmitis at Stanford Hospital in the modern medical era in that our rates may be different as those reported in the literature. This potential difference may be a reflection of treatment protocols and antibiotics currently in use at Stanford Hospital.
Conditions
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2011-03-28
- Last updated
- 2014-11-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01323868. Inclusion in this directory is not an endorsement.